Lacoptal 150mg Tablet
By Lacoptal
Rx
10 Tablet in a Strip

Composition
Lacosamide(150mg)

Manufacturer - Icon Life Sciences
Icon Life Sciences, Div. Of Mesmer Pharmaceuticals, No.202/6, Lane In.30, Phase-II, IDA, Cherlapally, Hyderabad, 500 051 AP

Expires on or after
May, 2026

liver
When using Lacoptal 150mg Tablet, it is important to exercise caution if you have liver disease. In such cases, your doctor may need to adjust the dosage of the tablet to ensure it is safe for you. It is advised not to use Lacoptal 150mg Tablet in patients with severe liver disease. Always consult your doctor for proper guidance on the use of this medication.

kidney
Caution should be taken when using Lacoptal 150mg Tablet in patients with severe kidney disease. Dose adjustment may be necessary. Consult your doctor for guidance.

alcohol
Caution is advised when using alcohol with Lacoptal 150mg Tablet. It is recommended to consult your doctor regarding alcohol consumption while taking this medication.

driving
Lacoptal 150mg Tablet may decrease alertness, affect vision, and cause dizziness or drowsiness. Refrain from driving if experiencing these symptoms as they can impair driving ability.

pregnancy
Lacoptal 150mg Tablet may not be safe during pregnancy, as animal studies have shown harmful effects on the baby's development. Your doctor will consider the benefits and risks before prescribing this medication to you. Please consult your doctor regarding its use during pregnancy.

breastfeeding
Lacoptal 150mg Tablet is likely unsafe while breastfeeding. Limited data indicates it may pass into breastmilk and harm the baby. If no information is available or safety advice is not known related to Breastfeeding, give output "It is better to consult your doctor before using Lacoptal 150mg Tablet".
Habit Forming | No |
Chemical Class | Amino acid Derivative |
Therapeutic Class | NEURO CNS |
Action Class | Sodium channel modulators (AED) |
₹204
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024